Eye - Table of Contents alert Volume 30 Issue 6

If you are unable to see the message below, click here to view.

Advertisement nature.com webcasts Nature Publishing Group presents a custom webcast on: Overcoming current challenges with 3D cell culturing Wednesday June 15, 2016 8AM PDT, 11AM EDT, 4PM BST, 5PM CEST Register for the webcast and live Q&A session Sponsored by: Lonza Bioscience Solutions Custom webcast: sponsor retains sole responsibility for content   TABLE OF CONTENTS Volume 30, Issue 6 (June 2016) In this issue Comment Review Clinical Studies Laboratory Study Case Series Correspondence Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Follow us on Twitter Advertisement Call for Papers: AMD Special Issue In January 2017, Eye will publish a special issue on age related macular degeneration (AMD). We invite authors to submit reviews, clinical and laboratory research papers that will provide scientific information applicable to clinical practice. Articles that pass the peer review process will appear in this special issue of Eye. Deadline for submission: 1st July 2016 Comment Top Comment on ‘The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary’ S S Hayreh Eye 2016 30: 771-772; advance online publication, April 8, 2016; 10.1038/eye.2016.63 Full Text Review Top Introduction to metabolomics and its applications in ophthalmology S Z Tan, P Begley, G Mullard, K A Hollywood and P N Bishop Eye 2016 30: 773-783; advance online publication, March 18, 2016; 10.1038/eye.2016.37 Abstract | Full Text Clinical Studies Top Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up M L Salvetat, M Zeppieri, C Tosoni and P Brusini Eye 2016 30: 784-795; advance online publication, May 13, 2016; 10.1038/eye.2016.86 Abstract | Full Text Prevalence and associated factors of myopia among primary and middle school-aged students: a school-based study in Guangzhou L Guo, J Yang, J Mai, X Du, Y Guo, P Li, Y Yue, D Tang, C Lu and W-H Zhang Eye 2016 30: 796-804; advance online publication, March 11, 2016; 10.1038/eye.2016.39 Abstract | Full Text Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy E Smretschnig, S Hagen, C Glittenberg, R Ristl, I Krebs, S Binder and S Ansari-Shahrezaei Eye 2016 30: 805-811; advance online publication, March 11, 2016; 10.1038/eye.2016.41 Abstract | Full Text The accuracy of the Edinburgh diplopia diagnostic algorithm L Butler, T Yap and M Wright Eye 2016 30: 812-816; advance online publication, March 18, 2016; 10.1038/eye.2016.44 Abstract | Full Text Prevalence of reticular pseudodrusen in newly presenting adult onset foveomacular vitelliform dystrophy C Wilde, A Lakshmanan, M Patel, M U Morales, S Dhar-Munshi and W M K Amoaku Eye 2016 30: 817-824; advance online publication, April 1, 2016; 10.1038/eye.2016.46 Abstract | Full Text Glucose variability and inner retinal sensory neuropathy in persons with type 1 diabetes mellitus M S Stem, G E Dunbar, G R Jackson, S Farsiu, R Pop-Busui and T W Gardner Eye 2016 30: 825-832; advance online publication, April 1, 2016; 10.1038/eye.2016.48 Abstract | Full Text Transscleral resection without hypotensive anaesthesia vs iodine-125 plaque brachytherapy in the treatment of choroidal melanoma J M Caminal, N Padrón-Pérez, L Arias, C Masuet-Aumatell, C Gutiérrez, J M Piulats, J Pera, J Català, M J Rubio and J Arruga Eye 2016 30: 833-842; advance online publication, April 1, 2016; 10.1038/eye.2016.49 Abstract | Full Text Intravitreal bevacizumab monotherapy for choroidal neovascularisation secondary to choroidal osteoma V P Papastefanou, M Pefkianaki, L Al Harby, A K Arora, V M L Cohen, R M Andrews and M S Sagoo Eye 2016 30: 843-849; advance online publication, April 1, 2016; 10.1038/eye.2016.50 Abstract | Full Text Finasteride is effective for the treatment of central serous chorioretinopathy E Moisseiev, A J Holmes, A Moshiri and L S Morse Eye 2016 30: 850-856; advance online publication, April 8, 2016; 10.1038/eye.2016.53 Abstract | Full Text The increase of aqueous tear volume by diquafosol sodium in dry-eye patients with Sjögren’s syndrome: a pilot study N Yokoi, H Kato and S Kinoshita Eye 2016 30: 857-864; advance online publication, April 8, 2016; 10.1038/eye.2016.54 Abstract | Full Text Development and validation of a Bayesian network for the differential diagnosis of anterior uveitis J J González-López, Á M García-Aparicio, D Sánchez-Ponce, N Muñoz-Sanz, N Fernandez-Ledo, P Beneyto and M C Westcott Eye 2016 30: 865-872; advance online publication, April 8, 2016; 10.1038/eye.2016.64 Abstract | Full Text Does delay in referral of proliferative diabetic retinopathy from the diabetic eye screening programme lead to visual loss? G S Negretti, R Amin, L Webster and C A Egan Eye 2016 30: 873-876; advance online publication, April 8, 2016; 10.1038/eye.2016.56 Abstract | Full Text Laboratory Study Top Silencing of S100A4, a metastasis-associated protein, inhibits retinal neovascularization via the downregulation of BDNF in oxygen-induced ischaemic retinopathy G Cheng, T He and Y Xing Eye 2016 30: 877-887; advance online publication, March 18, 2016; 10.1038/eye.2016.43 Abstract | Full Text Case Series Top Optical coherence tomography angiography in paracentral acute middle maculopathy secondary to central retinal vein occlusion G Casalino, M Williams, C McAvoy, F Bandello and U Chakravarthy Eye 2016 30: 888-893; advance online publication, April 1, 2016; 10.1038/eye.2016.57 Abstract | Full Text Correspondence Top Intravitreal aflibercept for refractory choroidal neovascularization secondary to angioid streaks M Tetikoglu, H M Sagdik, S Aktas and F Ozcura Eye 2016 30: 894-895; advance online publication, March 4, 2016; 10.1038/eye.2016.28 Full Text Intravitreal aflibercept for choroidal neovascularisation in angioid streaks S Vaz-Pereira, L Collaço, G De Salvo and P van Zeller Eye 2016 30: 896; advance online publication, March 4, 2016; 10.1038/eye.2016.34 Full Text Comment on: ‘Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab’ D Călugăru and M Călugăru Eye 2016 30: 896-897; advance online publication, March 4, 2016; 10.1038/eye.2016.31 Full Text Reply to ‘Comment on: Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab’ L C Olmos, M S Sayed and R K Lee Eye 2016 30: 897-898; advance online publication, March 4, 2016; 10.1038/eye.2016.32 Full Text Comment on: ‘Effectiveness of a smartphone application for testing near-visual acuity’ M Rodríguez-Vallejo Eye 2016 30: 898-899; advance online publication, March 4, 2016; 10.1038/eye.2016.35 Full Text Comment on: ‘Effectiveness of a smartphone application for testing near visual acuity’ I T Hossain, H H Malik and M Franka Eye 2016 30: 899-900; advance online publication, March 4, 2016; 10.1038/eye.2016.36 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Eye. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.